# Formfactor Inc: financial statements, quarterly

FORM · Nasdaq · CIK 1039399 · [Technology](/sectors/technology.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/form.md) · [Financials](/companies/form/financials.md) · [Filings](/companies/form/filings.md) · [Insiders](/companies/form/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/form/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [172](/filings/0001039399-24-000035.md) | [168 d](/filings/0001039399-26-000009.md) | [169](/filings/0001039399-25-000038.md) | [197](/filings/0001039399-25-000083.md) | [208](/filings/0001039399-25-000113.md) | [189 d](/filings/0001039399-26-000009.md) | [171](/filings/0001039399-26-000023.md) | [196](/filings/0001039399-26-000033.md) | [203](/filings/0001039399-25-000113.md) | [215 d](/filings/0001039399-26-000009.md) | [226](/filings/0001039399-26-000023.md) | [258](/filings/0001039399-26-000033.md) |
| Cost of revenue | $m | [102](/filings/0001039399-24-000035.md) | [100 d](/filings/0001039399-26-000009.md) | [106](/filings/0001039399-25-000038.md) | [111](/filings/0001039399-25-000083.md) | [123](/filings/0001039399-25-000113.md) | [116 d](/filings/0001039399-26-000009.md) | [107](/filings/0001039399-26-000023.md) | [123](/filings/0001039399-26-000033.md) | [122](/filings/0001039399-25-000113.md) | [124 d](/filings/0001039399-26-000009.md) | [139](/filings/0001039399-26-000023.md) | [127](/filings/0001039399-26-000033.md) |
| Gross profit | $m | [69.3](/filings/0001039399-24-000035.md) | [67.9 d](/filings/0001039399-26-000009.md) | [62.7](/filings/0001039399-25-000038.md) | [86.9](/filings/0001039399-25-000083.md) | [84.7](/filings/0001039399-25-000113.md) | [73.6 d](/filings/0001039399-26-000009.md) | [64.5](/filings/0001039399-26-000023.md) | [72.9](/filings/0001039399-26-000033.md) | [80.6](/filings/0001039399-25-000113.md) | [90.8 d](/filings/0001039399-26-000009.md) | [86.8](/filings/0001039399-26-000023.md) | [131](/filings/0001039399-26-000033.md) |
| Research and development | $m | [31.0](/filings/0001039399-24-000035.md) | [28.2 d](/filings/0001039399-26-000009.md) | [28.6](/filings/0001039399-25-000038.md) | [31.6](/filings/0001039399-25-000083.md) | [31.2](/filings/0001039399-25-000113.md) | [30.5 d](/filings/0001039399-26-000009.md) | [27.8](/filings/0001039399-26-000023.md) | [28.8](/filings/0001039399-26-000033.md) | [28.7](/filings/0001039399-25-000113.md) | [30.4 d](/filings/0001039399-26-000009.md) | [30.8](/filings/0001039399-26-000023.md) | [31.1](/filings/0001039399-26-000033.md) |
| Selling, general and administrative | $m | [35.6](/filings/0001039399-24-000035.md) | [31.5 d](/filings/0001039399-26-000009.md) | [33.1](/filings/0001039399-25-000038.md) | [37.9](/filings/0001039399-25-000083.md) | [35.6](/filings/0001039399-25-000113.md) | [35.2 d](/filings/0001039399-26-000009.md) | [33.5](/filings/0001039399-26-000023.md) | [31.5](/filings/0001039399-26-000033.md) | [33.0](/filings/0001039399-25-000113.md) | [35.2 d](/filings/0001039399-26-000009.md) | [32.3](/filings/0001039399-26-000023.md) | [37.2](/filings/0001039399-26-000033.md) |
| Operating income | $m | [2.7](/filings/0001039399-24-000035.md) | [81.3 d](/filings/0001039399-26-000009.md) | [21.3](/filings/0001039399-25-000038.md) | [17.8](/filings/0001039399-25-000083.md) | [17.9](/filings/0001039399-25-000113.md) | [7.9 d](/filings/0001039399-26-000009.md) | [3.3](/filings/0001039399-26-000023.md) | [12.3](/filings/0001039399-26-000033.md) | [18.0](/filings/0001039399-25-000113.md) | [23.5 d](/filings/0001039399-26-000009.md) | [16.6](/filings/0001039399-26-000023.md) | [57.8](/filings/0001039399-26-000033.md) |
| Interest expense | $m | not reported | not reported | [0.1](/filings/0001039399-25-000038.md) | not reported | not reported | not reported | [0.1](/filings/0001039399-25-000038.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.8](/filings/0001039399-24-000035.md) | [6.3 d](/filings/0001039399-26-000009.md) | [3.2](/filings/0001039399-25-000038.md) | [2.2](/filings/0001039399-25-000083.md) | [2.2](/filings/0001039399-25-000113.md) | [2.2 d](/filings/0001039399-26-000009.md) | [1.1](/filings/0001039399-26-000023.md) | [2.4](/filings/0001039399-26-000033.md) | [5.9](/filings/0001039399-25-000113.md) | [3.6 d](/filings/0001039399-26-000009.md) | [0.4](/filings/0001039399-26-000023.md) | [6.7](/filings/0001039399-26-000033.md) |
| Net income | $m | [4.4](/filings/0001039399-24-000035.md) | [75.8 d](/filings/0001039399-26-000009.md) | [21.8](/filings/0001039399-25-000038.md) | [19.4](/filings/0001039399-25-000083.md) | [18.7](/filings/0001039399-25-000113.md) | [9.7 d](/filings/0001039399-26-000009.md) | [6.4](/filings/0001039399-26-000023.md) | [9.1](/filings/0001039399-26-000033.md) | [15.7](/filings/0001039399-25-000113.md) | [23.2 d](/filings/0001039399-26-000009.md) | [20.4](/filings/0001039399-26-000023.md) | [56.2](/filings/0001039399-26-000033.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001039399-24-000035.md) | not reported | [0.28](/filings/0001039399-25-000038.md) | [0.25](/filings/0001039399-25-000083.md) | [0.24](/filings/0001039399-25-000113.md) | not reported | [0.08](/filings/0001039399-26-000023.md) | [0.12](/filings/0001039399-26-000033.md) | [0.20](/filings/0001039399-25-000113.md) | not reported | [0.26](/filings/0001039399-26-000023.md) | [0.71](/filings/0001039399-26-000033.md) |
| Basic EPS | $ per share | [0.06](/filings/0001039399-24-000035.md) | not reported | [0.28](/filings/0001039399-25-000038.md) | [0.25](/filings/0001039399-25-000083.md) | [0.24](/filings/0001039399-25-000113.md) | not reported | [0.08](/filings/0001039399-26-000023.md) | [0.12](/filings/0001039399-26-000033.md) | [0.20](/filings/0001039399-25-000113.md) | not reported | [0.26](/filings/0001039399-26-000023.md) | [0.72](/filings/0001039399-26-000033.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [109](/filings/0001039399-24-000035.md) | [178](/filings/0001039399-26-000009.md) | [186](/filings/0001039399-25-000038.md) | [196](/filings/0001039399-25-000083.md) | [185](/filings/0001039399-25-000113.md) | [191](/filings/0001039399-26-000009.md) | [130](/filings/0001039399-26-000023.md) | [67.4](/filings/0001039399-26-000033.md) | [97.7](/filings/0001039399-25-000113.md) | [103](/filings/0001039399-26-000033.md) | [124](/filings/0001039399-26-000023.md) | [110](/filings/0001039399-26-000033.md) |
| Current assets | $m | [507](/filings/0001039399-23-000049.md) | [574](/filings/0001039399-25-000023.md) | [588](/filings/0001039399-24-000016.md) | [621](/filings/0001039399-24-000028.md) | [615](/filings/0001039399-24-000035.md) | [605](/filings/0001039399-26-000009.md) | [551](/filings/0001039399-25-000038.md) | [525](/filings/0001039399-25-000083.md) | [559](/filings/0001039399-25-000113.md) | [557](/filings/0001039399-26-000033.md) | [601](/filings/0001039399-26-000023.md) | [670](/filings/0001039399-26-000033.md) |
| Total assets | $m | [1,033](/filings/0001039399-23-000049.md) | [1,107](/filings/0001039399-25-000023.md) | [1,120](/filings/0001039399-24-000016.md) | [1,156](/filings/0001039399-24-000028.md) | [1,154](/filings/0001039399-24-000035.md) | [1,146](/filings/0001039399-26-000009.md) | [1,156](/filings/0001039399-25-000038.md) | [1,182](/filings/0001039399-25-000083.md) | [1,203](/filings/0001039399-25-000113.md) | [1,224](/filings/0001039399-26-000033.md) | [1,256](/filings/0001039399-26-000023.md) | [1,342](/filings/0001039399-26-000033.md) |
| Current liabilities | $m | [130](/filings/0001039399-23-000049.md) | [131](/filings/0001039399-25-000023.md) | [131](/filings/0001039399-24-000016.md) | [139](/filings/0001039399-24-000028.md) | [129](/filings/0001039399-24-000035.md) | [131](/filings/0001039399-26-000009.md) | [124](/filings/0001039399-25-000038.md) | [124](/filings/0001039399-25-000083.md) | [130](/filings/0001039399-25-000113.md) | [124](/filings/0001039399-26-000033.md) | [132](/filings/0001039399-26-000023.md) | [164](/filings/0001039399-26-000033.md) |
| Total liabilities | $m | [192](/filings/0001039399-23-000049.md) | [198](/filings/0001039399-25-000023.md) | [196](/filings/0001039399-24-000016.md) | [208](/filings/0001039399-24-000028.md) | [199](/filings/0001039399-24-000035.md) | [198](/filings/0001039399-26-000009.md) | [190](/filings/0001039399-25-000038.md) | [192](/filings/0001039399-25-000083.md) | [193](/filings/0001039399-25-000113.md) | [189](/filings/0001039399-26-000033.md) | [197](/filings/0001039399-26-000023.md) | [231](/filings/0001039399-26-000033.md) |
| Long-term debt | $m | [13.6](/filings/0001039399-23-000049.md) | [13.3](/filings/0001039399-25-000023.md) | [13.0](/filings/0001039399-24-000016.md) | [12.8](/filings/0001039399-24-000028.md) | [12.5](/filings/0001039399-24-000035.md) | [12.2](/filings/0001039399-26-000009.md) | [11.9](/filings/0001039399-25-000038.md) | [11.6](/filings/0001039399-25-000083.md) | [11.4](/filings/0001039399-25-000113.md) | [11.1](/filings/0001039399-26-000033.md) | [10.8](/filings/0001039399-26-000023.md) | [10.5](/filings/0001039399-26-000033.md) |
| Current portion of debt | $m | [1.1](/filings/0001039399-23-000049.md) | [1.1](/filings/0001039399-25-000023.md) | [1.1](/filings/0001039399-24-000016.md) | [1.1](/filings/0001039399-24-000028.md) | [1.1](/filings/0001039399-24-000035.md) | [1.1](/filings/0001039399-26-000009.md) | [1.1](/filings/0001039399-25-000038.md) | [1.1](/filings/0001039399-25-000083.md) | [1.1](/filings/0001039399-25-000113.md) | [1.1](/filings/0001039399-26-000033.md) | [1.1](/filings/0001039399-26-000023.md) | [1.2](/filings/0001039399-26-000033.md) |
| Shareholders' equity | $m | [841](/filings/0001039399-24-000035.md) | [909](/filings/0001039399-26-000009.md) | [924](/filings/0001039399-25-000083.md) | [948](/filings/0001039399-25-000113.md) | [955](/filings/0001039399-25-000113.md) | [948](/filings/0001039399-26-000033.md) | [966](/filings/0001039399-26-000033.md) | [990](/filings/0001039399-26-000033.md) | [1,010](/filings/0001039399-25-000113.md) | [1,035](/filings/0001039399-26-000033.md) | [1,059](/filings/0001039399-26-000033.md) | [1,111](/filings/0001039399-26-000033.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [20.6 d](/filings/0001039399-24-000035.md) | [9.3 d](/filings/0001039399-26-000009.md) | [33.0](/filings/0001039399-25-000038.md) | [21.9 d](/filings/0001039399-25-000083.md) | [26.7 d](/filings/0001039399-25-000113.md) | [35.9 d](/filings/0001039399-26-000009.md) | [23.5](/filings/0001039399-26-000023.md) | [18.9 d](/filings/0001039399-26-000033.md) | [27.0 d](/filings/0001039399-25-000113.md) | [46.0 d](/filings/0001039399-26-000009.md) | [45.0](/filings/0001039399-26-000023.md) | [61.8 d](/filings/0001039399-26-000033.md) |
| Capital expenditure | $m | [5.9 d](/filings/0001039399-24-000035.md) | [9.9 d](/filings/0001039399-26-000009.md) | [13.4](/filings/0001039399-25-000038.md) | [8.4 d](/filings/0001039399-25-000083.md) | [8.9 d](/filings/0001039399-25-000113.md) | [7.7 d](/filings/0001039399-26-000009.md) | [18.6](/filings/0001039399-26-000023.md) | [66.3 d](/filings/0001039399-26-000033.md) | [7.5 d](/filings/0001039399-25-000113.md) | [11.3 d](/filings/0001039399-26-000009.md) | [15.2](/filings/0001039399-26-000023.md) | [9.6 d](/filings/0001039399-26-000033.md) |
| Share repurchases | $m | [0.0 d](/filings/0001039399-24-000035.md) | [19.8 d](/filings/0001039399-26-000009.md) | [17.3](/filings/0001039399-25-000038.md) | [2.9 d](/filings/0001039399-25-000083.md) | [16.9 d](/filings/0001039399-25-000113.md) | [16.1 d](/filings/0001039399-26-000009.md) | [22.1](/filings/0001039399-26-000023.md) | [2.5 d](/filings/0001039399-26-000033.md) | [1.7 d](/filings/0001039399-25-000113.md) | [0.0 d](/filings/0001039399-26-000009.md) | [0.0](/filings/0001039399-26-000023.md) | [0.0 d](/filings/0001039399-26-000033.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-24) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [77.7](/filings/0001039399-23-000049.md) | [77.3](/filings/0001039399-24-000016.md) | [77.6](/filings/0001039399-24-000028.md) | [78.4](/filings/0001039399-24-000035.md) | [78.5](/filings/0001039399-25-000038.md) | [78.7](/filings/0001039399-25-000083.md) | [78.4](/filings/0001039399-25-000113.md) | [77.9](/filings/0001039399-26-000023.md) | [77.5](/filings/0001039399-26-000033.md) | [77.7](/filings/0001039399-25-000113.md) | [79.4](/filings/0001039399-26-000023.md) | [79.6](/filings/0001039399-26-000033.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 78,120,725 at 2026-07-29, from the cover of the [10-Q filed 2026-08-04](/filings/0001039399-26-000033.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.